14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
2020 is on the horizon, and employers must be ready to comply with many new developments in the worl...
Read More >
Under the leadership of Margrethe Vestager, the European Commission has taken an increasing interven...
Read More >
On February 26, 2020, the United States Supreme Court, in a unanimous decision by Justice Samuel Ali...
Read More >
Seyfarth Synopsis: On the heels of last week’s federal court order temporarily blocking enforcement...
Read More >
Following the prime minister’s announcement that free movement will come to an end, the UK governme...
Read More >
The Financial Services Regulatory Authority of Ontario (FSRA) has announced a “one-time opportunity...
Read More >